Therapy of rhabdomyosarcoma of the larynx.
A case of subglottic rhabdomyosarcoma in a 13-year-old boy is reported. Following partial conservative resection of the larynx with supplementary chemotherapy and without irradiation, the patient has had no functional impairment of the larynx and has shown no evidence of recurrence for more than 3 years.
Gross
M
M
ENT-Clinic, Johannes Gutenberg-University Hospital Mainz, F.R.G.
Gutjahr
P
P
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D007828:Laryngoscopy; D007830:Larynx / Q000601:surgery; D008297:Male; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D014750:Vincristine / Q000008:administration & dosage
D003609:Dactinomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide